Raymond James Financial Services Advisors Inc. Boosts Stake in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)


Raymond James Financial Services Advisors Inc. grew its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,746 shares of the company’s stock after buying an additional 63 shares during the quarter. Raymond James Financial Services Advisors Inc. owned 0.26% of iShares US Pharmaceuticals ETF worth $975,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. First Manhattan Co. purchased a new position in iShares US Pharmaceuticals ETF in the 1st quarter worth $46,000. Venture Visionary Partners LLC purchased a new position in iShares US Pharmaceuticals ETF in the 2nd quarter worth $53,000. Hallmark Capital Management Inc. bought a new stake in iShares US Pharmaceuticals ETF in the 2nd quarter worth $57,000. Blair William & Co. IL bought a new stake in iShares US Pharmaceuticals ETF in the 1st quarter worth $58,000. Finally, Magnus Financial Group LLC bought a new stake in iShares US Pharmaceuticals ETF in the 2nd quarter worth $204,000.

iShares US Pharmaceuticals ETF Price Performance

Shares of iShares US Pharmaceuticals ETF stock opened at $185.58 on Friday. iShares US Pharmaceuticals ETF has a 12-month low of $166.99 and a 12-month high of $202.77. The company’s fifty day simple moving average is $185.51 and its two-hundred day simple moving average is $182.90.

About iShares US Pharmaceuticals ETF

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Read More

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating).

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)



Receive News & Ratings for iShares US Pharmaceuticals ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

Source Link

Leave a Comment

We Are Prowdly Hosted On

Get 20% Off By Using Our Referral Code - 1SUBODHKAUS10